By partnering with companies across the life sciences spectrum, private equity is building better businesses — providing financial support and strategic advice to develop innovative technologies and devices that benefit patients and improve lives. The AIC and Pitchbook recently released a new report, “Improving Medical Technologies: Private Equity’s Role in Life Sciences,” that showcases how private equity is playing an increasingly important role in the growth and continued strength of the life sciences industry.
health caresPRIVATE EQUITY IS IMPROVING HEALTH CARE
For decades, private equity-funded innovations have delivered more effective
treatments and saved lives — and, importantly, helped lower health care costs and
increase access to lifesaving care for millions of Americans.
According to data compiled by Pitchbook, private equity invested more than $206 billion in U.S. health care throughout 2021 to fund research into deadly diseases like Alzheimer’s and Parkinson’s, expand and renovate facilities, modernize medical records and health care data, and make other needed investments.
Investing in Medical Technologies
that Improve Lives
$280B
invested by private equity across more than 1,800 life sciences and medical device companies in the U.S.
$36B
invested to support life sciences and medical device companies during the pandemic.
900+
medical device and supply companies have been supported by private equity firms in the last 10.
Increasing Health Care Access by Investing in Urgent Care Centers
Rural America has a profound health care deficit, and much of that problem boils down to a lack of resources: relatively few providers, less insurance coverage, and fewer health care professionals compared to urban and suburban areas. Fortunately, private equity is filling that gap by investing in urgent care providers that have identified business models that work in rural and underserved communities.
How is PE filling the gaps?
Private equity deals in outpatient clinics such as urgent cares have expanded in the past five years, with more than 250 deals completed in 2020 for more than $15 billion in value.
dummy-1[1]Private Equity’s Improves Patient Care and Drives Innovation
For decades, private equity-funded innovations have delivered more effective treatments and saved lives.
Short header here
invested by private equity across more than 1,800 life sciences and medical device companies in the U.S.
Short header here
invested by private equity across more than 1,800 life sciences and medical device companies in the U.S.
Short header here
invested by private equity across more than 1,800 life sciences and medical device companies in the U.S.
Short header here
invested by private equity across more than 1,800 life sciences and medical device companies in the U.S.
Short header here
invested by private equity across more than 1,800 life sciences and medical device companies in the U.S.
Short header here
invested by private equity across more than 1,800 life sciences and medical device companies in the U.S.
Short Subhead goes here
PRIVATE EQUITY IS IMPROVING HEALTH CARE
For decades, private equity-funded innovations have
delivered more effective treatments and saved lives —
and, importantly, helped lower costs and increase
access to lifesaving care for millions of Americans.